# Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China

> **NCT03064841** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1537 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** No Treatment

## Key facts

- **NCT ID:** NCT03064841
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-09
- **Primary completion:** 2017-12-30
- **Final completion:** 2017-12-30
- **Target enrollment:** 1537 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03064841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03064841, "Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03064841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*